According to FDA prescribing information, the most common side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose escalation
Pregnant or breastfeeding individuals No safety data exists for cagrilintide use during pregnancy or breastfeeding
IMPORTANT:Tizaro contains just 1 week dose
PDP covers four weight management stacks: CagriSema (cagrilintide + semaglutide), Cagrilintide + Tirzepatide, Cagrilintide + Retatrutide, and Retatrutide + MOTS-c
For weight management in the UK, NICE-approved options are limited to orlistat (available over-the-counter or on prescription) and, within specialist weight management services, liraglutide 3.0mg (Saxenda) or semaglutide 2.4mg (Wegovy) with their specific continuation criteria